What to watch with FADS1 and menopause?

FADS1 encodes delta‑5‑desaturase, an enzyme that converts precursor fatty acids into biologically active omega‑3 and omega‑6 fatty acids. Genetic variants in FADS1 have been linked in several studies to lipid profiles, inflammatory responses, and hormonal changes. Among post‑menopausal women, certain alleles correlate with lower omega‑3 levels and slightly higher inflammation, which can influence hot‑flushes, mood swings, or bone density. The evidence is mainly human observational and GWAS‑based, so it is weak to moderate, as the effect size is small and often entangled with other genes and environmental factors. For consumers, a DNA test indicating a FADS1 variant provides no immediate clinical action: the evidence is insufficient to replace physician advice. Nevertheless, an abnormal lipid profile or an unexpected fatty‑acid composition can serve as a discussion point with an OB‑GYN or endocrinologist, especially if menopausal symptoms are emerging or worsening. It is prudent to consider individualized diet, exercise, and possibly omega‑3 supplementation in conjunction with professional guidance. Safety note: Any medication or diet adjustment should be aligned with expert counsel and evidence‑based practice.